読み込み中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$73.89
+$1.91 · +2.65%
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
最新データ
$73.89
+$1.91 · +2.65%
日中の時刻はETです。市場データは遅延する場合があります。
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
95
大幅な割安
センチメント
49
まちまち
リスク
29
中程度のリスク
モメンタム
46
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 8.83億 USD | 6.14億 USD | 4.87億 USD | 3.16億 USD | 2.16億 USD |
| 売上原価 | 4.33億 USD | 2.5億 USD | 1.82億 USD | 1.39億 USD | 1.01億 USD |
| 粗利益 | 4.51億 USD | 3.64億 USD | 3.05億 USD | 1.78億 USD | 1.16億 USD |
| 研究開発 | 5166.4万 USD | 4458.1万 USD | 3428.6万 USD | 2231.8万 USD | 1136.9万 USD |
| 販売・一般管理 | 3.18億 USD | 2.5億 USD | 1.62億 USD | 1.24億 USD | 8429.4万 USD |
| 営業費用 | 3.69億 USD | 3.64億 USD | 2.58億 USD | 2.13億 USD | 1.55億 USD |
| 支払利息 | 2006万 USD | 1760.2万 USD | 2694万 USD | 2805.2万 USD | 1192.2万 USD |
| 減価償却費と償却費 | 9141.7万 USD | 6773.1万 USD | 5979.1万 USD | 5965.3万 USD | 4725.2万 USD |
| 営業利益 | 8123万 USD | 58.4万 USD | 4697.1万 USD | −3528.3万 USD | −3979.3万 USD |
| 純利益 | 7833.7万 USD | −1852.2万 USD | 1877.9万 USD | −4789.6万 USD | −4260.3万 USD |
会社概要が更新されました 2026年10月12日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$99.50
上昇余地（34.66%）この株式へのエクスポージャーを報告している上場投資信託です。
iShares Core S&P Small-Cap ETFIJR8656.48万0.08%1031.91億 USD0.06%$137.55+0.17%
Avantis U.S. Small Cap Value ETFAVUV5403.17万0.17%308.51億 USD0.25%$119.64-0.41%
Vanguard Morningstar Total Stock Market ETFVTI4502.11万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM3877.65万0.05%787.4億 USD0.19%$278.94+0.49%
Invesco Pharmaceuticals ETFPJP1723.19万3.14%5.48億 USD0.58%$122.88+1.56%
Vanguard Extended Market ETFVXF1547.39万0.02%954億 USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO1359.64万0.10%139.17億 USD0.24%$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1331.54万0.08%158.4億 USD0.03%$53.45+0.17%iShares Core S&P Small-Cap ETFIJRAvantis U.S. Small Cap Value ETFAVUVVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMInvesco Pharmaceuticals ETFPJPVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
